Citigroup’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-8,988
| Closed | -$10.1K | – | 6200 |
|
|
2025
Q2 | $10.1K | Sell |
8,988
-2,726
| -23% | -$3.33K | ﹤0.01% | 5187 |
|
|
2025
Q1 | $13.5K | Sell |
11,714
-537
| -4% | -$999 | ﹤0.01% | 5151 |
|
|
2024
Q4 | $74.9K | Buy |
12,251
+1,286
| +12% | +$15.3K | ﹤0.01% | 4957 |
|
|
2024
Q3 | $181K | Buy |
10,965
+7,645
| +230% | +$83.7K | ﹤0.01% | 4410 |
|
|
2024
Q2 | $22.8K | Buy |
3,320
+796
| +32% | +$6.81K | ﹤0.01% | 4966 |
|
|
2024
Q1 | $24.4K | Buy |
2,524
+637
| +34% | +$7.38K | ﹤0.01% | 4969 |
|
|
2023
Q4 | $15.7K | Buy |
1,887
+1,450
| +332% | +$8.42K | ﹤0.01% | 5068 |
|
|
2023
Q3 | $3.65K | Sell |
437
-3,945
| -90% | -$33.5K | ﹤0.01% | 4805 |
|
|
2023
Q2 | $40.4K | Buy |
4,382
+3,451
| +371% | +$38.7K | ﹤0.01% | 4749 |
|
|
2023
Q1 | $12.8K | Buy |
931
+236
| +34% | +$4.88K | ﹤0.01% | 4651 |
|
|
2022
Q4 | $11.8K | Sell |
695
-46
| -6% | -$920 | ﹤0.01% | 4791 |
|
|
2022
Q3 | $17K | Sell |
741
-574
| -44% | -$11.6K | ﹤0.01% | 4799 |
|
|
2022
Q2 | $23K | Sell |
1,315
-1,379
| -51% | -$24.6K | ﹤0.01% | 4919 |
|
|
2022
Q1 | $72K | Sell |
2,694
-41,668
| -94% | -$776K | ﹤0.01% | 4575 |
|
|
2021
Q4 | $1.3M | Buy |
44,362
+24,037
| +118% | +$1.19M | ﹤0.01% | 2982 |
|
|
2021
Q3 | $1.34M | Sell |
20,325
-20,267
| -50% | -$1.55M | ﹤0.01% | 2861 |
|
|
2021
Q2 | $3.38M | Sell |
40,592
-6,512
| -14% | -$482K | ﹤0.01% | 2252 |
|
|
2021
Q1 | $3.61M | Buy |
47,104
+43,212
| +1,110% | +$3.93M | ﹤0.01% | 2057 |
|
|
2020
Q4 | $343K | Buy |
3,892
+3,354
| +623% | +$236K | ﹤0.01% | 4535 |
|
|
2020
Q3 | $40K | Sell |
538
-4,781
| -90% | -$283K | ﹤0.01% | 5734 |
|
|
2020
Q2 | $388K | Buy |
5,319
+3,839
| +259% | +$233K | ﹤0.01% | 4491 |
|
|
2020
Q1 | $83K | Buy |
1,480
+486
| +49% | +$21.3K | ﹤0.01% | 5502 |
|
|
2019
Q4 | $38K | Buy |
+994
| New | +$25K | ﹤0.01% | 6529 |
|
Other funds holding IGMS
Citigroup's IGMS Position: Q3 2025 in Review
Citigroup sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 8,988 shares — an estimated $10.1K sold.
Citigroup first reported a position in IGMS in Q4 2019 and held it in 23 quarters. The position peaked at $3.61M in Q1 2021. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- Citigroup reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- Citigroup sold 8,988 IGM Biosciences shares in Q3 2025, an estimated $10.1K.
- Citigroup first reported a position in IGM Biosciences in Q4 2019 and held it in 23 quarters.
- Citigroup's IGM Biosciences position peaked at $3.61M in Q1 2021.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on Citigroup's 13F filing for Q3 2025, filed 10 Nov 2025.